Journal of Clinical Immunology

, Volume 32, Issue 6, pp 1193–1196 | Cite as

Acidomonas Methanolica-Associated Necrotizing Lymphadenitis in a Patient with Chronic Granulomatous Disease

  • John M. ChaseEmail author
  • Steven M. Holland
  • David E. Greenberg
  • Kimberly Marshall-Batty
  • Adrian M. Zelazny
  • Joseph A. ChurchEmail author



Adenitis for which no causative organism can be isolated is a common occurrence in patients with chronic granulomatous disease (CGD). Here we identify Acidomonas methanolica as a pathogen associated with adenitis in a patient with CGD.


The causative pathogen was obtained after prolonged incubation of an excised lymph node in thioglycolate broth. Identification was carried out by sequencing the 16s rRNA. Immunoblots were prepared utilizing protein extracts from the case patient’s A. methanolica isolate, an ATCC type strain of A. methanolica and G. bethesdensis.


Fastidious gram-negative rods grew after prolonged incubation of an excised lymph node in thioglycolate broth. Sequencing of the 16s rRNA identified the organism as A. methanolica. Immunoblot confirmed the pathogen’s role in the patient’s adenitis by showing the patient’s specific immune response to the organism.


A. methanolica is the second member of the family, Acetobacteaceae to be associated with adenitis in patients with CGD.


Chronic granulomatous disease Acidomonas methanolica 



Funding: Department of Laboratory Medicine, National Institutes of Health


  1. 1.
    Winkelstin JA, Marino MC, Johnston Jr RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155–69.CrossRefGoogle Scholar
  2. 2.
    Lestini BJ, Church JA. Trichosporon pullulans as a complication of chronic granulomatous disease in a patient undergoing immunosuppressive therapy for inflammatory bowel disease. Pediatr Infect Dis J. 2006;25(1):87–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Greenberg DE, Ding L, Zelazny AM, et al. A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS Pathog. 2006;2(4):e28. Epub 2006 Apr. 14.PubMedCrossRefGoogle Scholar
  4. 4.
    Greenberg DE, Shoffner AR, Zelazny AM, et al. Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease. Emerg Infect Dis. 2010;16(9):1341–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Gerard B, El Benna J, Alcain F, Gougerot-Pocidola MA, Grandchamp B, Chollet-Martin S. Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene). Hum Mutat. 2001;18(2):163.PubMedCrossRefGoogle Scholar
  6. 6.
    Greenberg DE, Porcella SF, Zelazny AM, et al. Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis. J Bacteriol. 2007;189(23):8727–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Sokollek SJ, Hertel C, Hammes WP. Description of Acetobacter oboediens sp. nov. and Acetobacter pomorum sp. nov., two new species isolated from industrial vinegar fermentations. Int J Syst Bacteriol. 1998;48:935–40.PubMedCrossRefGoogle Scholar
  8. 8.
    Alauzet C, Teyssier C, Jumas-Bilak E, et al. Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteria. J Clin Microbiol. 2010;48(11):3935–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Yamashita S, Uchimura T, Komagata K. Emendation of the genus Acidomonas Urakami, Tamaoka, Suzuki, and Komagata 1989. Int J Syst Evol Microbiol. 2004;54:865–70.PubMedCrossRefGoogle Scholar
  10. 10.
    Uhlig H, Karbaum K, Steudel A. Acetobacter methanolicus sp. nov., an acidophilic facultatively methylotrophic bacterium. Int J Syst Bacteriol. 1986;36:317–22.CrossRefGoogle Scholar
  11. 11.
    Urakami T, Tamaoka J, Suzuki KI, Komagata K. Acidomonas gen. nov. Incorporating Acetobacter methanolicus as Acidomonas methanolica comb. nov. Int J Syst Bacteriol. 1989;39:50–5.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • John M. Chase
    • 1
    Email author
  • Steven M. Holland
    • 2
  • David E. Greenberg
    • 2
    • 5
  • Kimberly Marshall-Batty
    • 2
    • 5
  • Adrian M. Zelazny
    • 2
    • 3
  • Joseph A. Church
    • 4
    Email author
  1. 1.Division of General Pediatrics, MS#75, Children’s Hospital Los Angeles and Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  2. 2.Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA
  3. 3.Microbiology Service, Department of Laboratory Medicine, Clinical CenterNational Institutes of HealthBethesdaUSA
  4. 4.Division of Clinical Immunology and Allergy, MS#75, Children’s Hospital Los Angeles and Keck School of MedicineUniversity of Southern CaliforniaLos AngelesUSA
  5. 5.Division of Infectious DiseasesUniversity of Texas SouthwesternDallasUSA

Personalised recommendations